Abstract
The human pathogens Yersinia pseudotuberculosis and Yersinia enterocolitica cause enterocolitis, while Yersinia pestis is responsible for pneumonic, bubonic, and septicaemic plague. All three share an infection strategy that relies on a virulence factor arsenal to enable them to enter, adhere to, and colonise the host while evading host defences to avoid untimely clearance. Their arsenal includes a number of adhesins that allow the invading pathogens to establish a foothold in the host and to adhere to specific tissues later during infection. When the host innate immune system has been activated, all three pathogens produce a structure analogous to a hypodermic needle. In conjunction with the translocon, which forms a pore in the host membrane, the channel that is formed enables the transfer of six ‘effector’ proteins into the host cell cytoplasm. These proteins mimic host cell proteins but are more efficient than their native counterparts at modifying the host cell cytoskeleton, triggering the host cell suicide response. Such a sophisticated arsenal ensures that yersiniae maintain the upper hand despite the best efforts of the host to counteract the infecting pathogen.
Keywords: Yersinia pestis, yersiniae, ail locus, pH6 antigen, virulence factors
Introduction
Across an infection timeline, the host and invading bacterial pathogen each vie for supremacy. At any given time, either may have the upper hand, but the final outcome of this battle ultimately determines the fate of the host. The triggered host response will aim to reduce the infectivity of the pathogen, but in order to stay one step ahead many bacterial species have evolved sophisticated strategies to ensure they can successfully cause infection following colonisation.
The three human pathogens belonging to the genus Yersinia employ a range of virulence factors that confer efficient adherence to host cells/tissues and subvert host cell functions. This mini-review highlights the key virulence factors that constitute the virulence arsenal of Yersinia spp. and how such a sophisticated suite of biological weapons enables these pathogens to combat host defences.
Yersinia pseudotuberculosis, Yersinia pestis, and Yersinia enterocolitica are highly adaptable psychrotrophic primary human pathogens. Y. pseudotuberculosis and Y. enterocolitica cause self-limiting gastric infections. Y. pestis is a recently evolved near-identical subclone of Y. pseudotuberculosis 1, 2 with approximately 98% identity at the DNA level. Its strategy for transmission relies on the colonisation of rat fleas, which then carry Y. pestis between the rodent host and humans 3. Once inside the human host, Y. pestis can cause bubonic, pneumonic, and septicaemic plague with mortality rates approaching 100% without antibiotic treatment 4. The World Health Organisation considers Y. pestis a ‘re-emerging’ pathogen that, worryingly, is capable of acquiring resistance to multiple antibiotics 5 and is also a serious potential bioterrorism threat. The differences in lifestyle and virulence between Y. pseudotuberculosis and Y. pestis are mostly attributable to minor genomic differences on the respective chromosomes and the presence of two additional virulence plasmids that Y. pestis possesses.
The Yersinia type three secretion system
The key Yersinia virulence determinants and certainly the most comprehensively studied are those secreted via a type three secretion system (T3SS). To evade host innate immunity and to enable the pathogen to replicate and propagate extracellularly, all human pathogenic Yersinia species harbour an approximately 70 kb virulence plasmid. Located on this plasmid is a set of genes whose transcription is activated by temperatures of 37 °C in the presence of millimolar concentrations of calcium, conditions representing the mammalian host. These genes code for the T3SS ‘nanomachine’, a hypodermic needle-like structure (the injectisome) and the translocon, which forms a pore across the host cell membrane ( Figure 1). Along with a combination of regulators and chaperones, the T3SS’s primary function is to inject multiple toxic Yersinia effector proteins (Yops) directly into the eukaryotic host cell cytosol. Once inside, they subvert host cell signalling pathways and trigger a pre-programmed metabolic chain reaction that results in apoptosis 6, 7. Yops also inhibit phagocytosis and block cytokine production.
The structure of the T3SS needle and translocon
Structurally, the base of the injectisome is composed of a number of proteins that adopt a cylindrical architecture similar to that of the flagellar basal body 8 that are directed to the membrane by the secretion (Sec)-dependent pathway 9. The injectisome incorporates two membrane rings termed the MS (membrane and supramembrane) and OM (outer membrane) rings. These are connected to five integral membrane proteins that play a role in exporting proteins 10, 11 ( Figure 1). The export apparatus itself is flanked by YscQ, which facilitates the binding of the ATPase YscN and the secretion substrate-chaperone complexes 12. YscN provides the proton motive force necessary for driving the secretion of the Yop effectors 9, 13, 14.
Protruding into the extracellular space from the basal body is a hollow needle formed by the helical polymerisation of YscF protein subunits 9, 15, 16. YscF is exported and polymerised in a T3SS-dependent manner along with YscP, a protein akin to a molecular ruler that determines the length of the needle and limits its size 17– 19. It has recently been shown that fully formed T3SS needles form clusters on the bacterial cell surface and new needles appear to localise to these clusters rather than being randomly distributed 20 ( Figure 2). The needle tip is capped with LcrV 21, 22, a protein that directs the formation of a pore or ‘translocon’ 23. The translocon consists of a tripartite protein pore, which is inserted into host cell membranes and drives the translocation of Yop effectors into the host target cell cytoplasm. The pore is composed of the transmembrane proteins YopB and YopD 23 and the injectisome tip complex LcrV 24– 26. Bacteria lacking the tip and translocon proteins are able to secrete effectors into the extracellular environment but are defective in translocating Yops into host cells 27– 29.
Chaperones facilitate the formation and operation of the T3SS
Given the complexity of the T3SS, part of its sophistication relates to its in-built ability to discriminate between structural and secretion substrates, providing strict order to ensure the needle is assembled and polymerised before translocon and Yop effector secretion 30. Such ordering requires specific chaperones, typically small protein dimers that protect the target T3SS protein from degradation 31, 32 and prevent premature oligomerisation 24 and also ushering into the injectisome. These T3SS chaperones are usually subdivided into three classes: class I chaperones bind the Yop effector proteins and often share high structural conservation, class II chaperones associate with the translocon proteins YopB, YopD, and LcrV, and class III chaperones tend to form heterodimers and associate with structural components of the injectisome.
The Yop effectors
The Yop effector proteins are virulence factors synthesised in the bacterial cytoplasm and secreted through the T3SS needle and translocon into eukaryotic target cells ( Figure 1). Four of these (YopE, YopT, YpkA, and YopH) are involved in disrupting the normal activities of the cytoskeleton and, apart from YopH, also target an important group of eukaryotic cell signalling components, the RhoA family of small GTPases that direct cytoskeletal rearrangements necessary for phagocytosis. YopE is a functional mimic of eukaryotic GTPase-activating proteins (GAPs) 33 and disrupts the actin cytoskeleton 34– 36, resulting in the inhibition of phagocytosis by macrophages. YopT suppresses RhoA-mediated signalling by cleaving the post-translationally modified Rho GTPases 37, which ultimately prevents the formation of the phagocytic cup for bacterial internalisation, and inhibits the assembly of focal adhesion complexes required for the development of pseudopodia and macrophage migration 38, 39. YpkA (YopO in Y. enterocolitica) associates with RhoA family proteins 40, 41 and inhibits phagocytosis 42, 43 by binding to and phosphorylating actin that is used as bait by Y. enterocolitica to titrate out host regulators responsible for actin polymerisation 44. YopH is multi-functional and disrupts pathways involved in both innate and adaptive immunity and is essential for the virulence of Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica in mice 45– 47. YopH inhibits autophagy following binding of invasin or YadA (see next section) to β1-integrins 48 and also blocks phagocytosis in macrophages 49, 50 by dephosphorylating focal adhesion complex proteins, which disrupts the link to the actin cytoskeleton 51, 52.
The remaining two effectors (YopJ and YopM) down-regulate elements of the immune system, such as inflammation and leukocyte recruitment 53– 57. YopJ (YopP in Y. enterocolitica) is a serine/threonine/lysine acetyltransferase that catalyses the acylation of kinases, inhibiting their ability to activate the release of NF-Κβ, which would otherwise induce pro-inflammatory cytokine production 58– 62. Recently, YopJ was also shown to play an important role in inhibiting caspase-1 in activated macrophages 63.
YopM is translocated into macrophages 64 and may also be able to self-deliver into some human cells 65, yet it has no known enzymatic activity 66 and its true function has yet to be elucidated. Inside eukaryotic cells, YopM may interact with and stimulate cellular kinases 67 and is thought to localise to the nucleus 68– 70, where it may influence the expression of a range of genes, down-regulating many pro-inflammatory cytokines 65, 71, counteract the innate immune system by promoting depletion of natural killer cells in the liver, spleen, and blood 72, and also prevent pyroptosis by binding to caspase-1, inhibiting its activity 73, 74.
Yersinia surface adhesins
For yersiniae to efficiently deliver Yops into the host, it is essential that they adhere to the host cell surface and remain in close association during the delivery process. To ensure that this is possible, the yersiniae produce virulence factors in addition to the T3SS. An active T3SS can deliver effector proteins into the host cell cytosol only if the bacterial cells make direct contact with, and bind tightly to, the host cell surface. Over the last 30 years, several chromosomally or plasmid-encoded protein virulence factors have been identified that play a variety of roles in host cell attachment prior to effector protein injection. In each case, attachment is not their exclusive function and not all are present or active in all three of the human pathogens. However, a combination of these proteins confers the ability to adhere to and invade host cells or bind sufficiently to ensure successful T3SS delivery of Yops.
Invasin
Invasin is a chromosomally encoded protein that mediates attachment to and entry into host cells by Y. pseudotuberculosis and Y. enterocolitica 75, although in Y. pestis it is a pseudogene and therefore inactive 76 ( Figure 3). Invasin promotes small intestine epithelial cell internalisation by binding to host cell target receptors known as β1-integrins 77 that present on the host cell surface. Integrins form clusters upon invasin binding, and the result is the rearrangement of the host cell cytoskeleton. This promotes phagocytosis and ultimately internalisation of the bacteria into the epithelial cells. In fact, invasin has a significantly greater (up to 100 times) affinity for some integrins than its natural ligand, fibronectin 78, and such strong associations are believed to be major contributing factors to the efficiency of internalisation and Yop delivery into host cells.
Invasin expression is regulated by both temperature and pH in Y. enterocolitica 79, 80. The invasin gene is maximally expressed at 26°C, peaking during late exponential/early stationary phase with lower expression levels observed at 37°C. This apparent contradiction, since invasin is required for infection at 37°C, was resolved when Pepe et al. revealed that the expression of invasin at 37°C was restored to levels seen at 26°C when the pH was reduced to 5.5. It has been suggested that rather than an experimental artefact, the expression of invasin at ambient temperatures could prepare the bacteria for infection following ingestion and promote rapid transcytosis through the epithelia 81, 82. The pH effect is not evident in Y. pseudotuberculosis, suggesting that the mechanisms of regulation of invasin expression may differ between the two species 83. Two regulators have been found to be important for invasin expression: RovA, required for the positive regulation of invasin, and YmoA, required for negative regulation 83– 85. Both RovA and YmoA recognise the promoter region of invasin and compete for binding. Once RovA is bound, it appears to prevent YmoA from binding, thus inhibiting negative regulation of invasin 86, 87. The expression of rovA is itself regulated by temperature via RovM, which acts as a repressor of rovA expression under inducing growth conditions 88.
YadA
After crossing the intestinal epithelium, the major adhesin responsible for Yersinia contact with cells of the submucosa is the virulence plasmid-encoded protein YadA (recently reviewed by Mühlenkamp et al. 89) ( Figure 3). YadA expression is induced at or above 37°C 90, 91, and under these conditions it is so abundant that it can virtually coat the entire outer surface of the bacterial cell 92. Interestingly, despite YadA’s utility and abundance, Y. pestis possesses an inactive yadA pseudogene due to a single nucleotide deletion that results in a frame-shift mutation 93 ( Figure 3). Although Y. pestis does not produce a functional YadA protein, the chromosome carries two orthologues, YadB and YadC. Also found in Y. pseudotuberculosis, these two proteins are not thought to play a role in adherence but may contribute to host cell invasion. They may also be required for full virulence and lethality in bubonic but not pneumonic plague in mouse infection models 94.
YadA is a non-fimbrial adhesin 95 belonging to the trimeric autotransporter adhesin family members, which are usually referred to as obligate homotrimeric proteins. The protein is shaped like a lollipop, with an N-terminal globular head domain connected by a coiled-coil stalk to a C-terminal anchor domain embedded in the outer membrane 92. YadA has multiple functions but as an adhesin may act as a docking system, allowing the injectisome of the T3SS to come into contact with the target cell membrane to deliver the Yop effector proteins 96.
Until recently, it was thought that YadA bound only to the large proteins of the extracellular matrix – collagen, fibronectin, and laminin – which in turn bind β1-integrins 97– 99. However, Keller et al. 100 recently discovered that YadA-mediated adhesion may be facilitated by a broad range of host cell receptors and in the absence of β1-integrins may facilitate Yop injection via αV integrins as well as other unidentified cofactors. Y. enterocolitica YadA also binds leukocytes in a β1-integrin-independent manner during systemic infection 101, all of which suggests that YadA has the potential to target a broad range of cell types to ensure efficient Yop delivery.
The collagen-binding activity of YadA in Y. enterocolitica is an absolute requirement for pathogenicity; however, YadA is not essential for virulence in Y. pseudotuberculosis 97. YadA mediates adhesion to a number of cell types, including epithelial cells and macrophages, and can act as a haemagglutinin 97. In Y. pseudotuberculosis, YadA promotes the invasion of epithelial cells and is interchangeable with the activity of invasin 102, although Y. enterocolitica YadA is not as efficient an invasin as that of Y. pseudotuberculosis 103. YadA also mediates bacteria-bacteria autoagglutination, since the head domain has an affinity for itself 92. This self-affinity also promotes the formation of densely packed microcolonies that may promote antiphagocytic activity in Y. enterocolitica. YadA also binds to intestinal mucus 104 and plays a major role in conferring serum resistance 105– 107.
Ail
The ail locus is chromosomally located and encodes a 17 kDa surface-associated protein ( Figure 3) that is thermally regulated, being maximally expressed at 37°C 108, 109. In Y. enterocolitica, Ail-directed adhesion to host cells shows more specificity than invasin, as it allows invasion of some cell lines, such as human laryngeal epithelial type 2 (HEp-2), human endometrial (HEC-1B), and Chinese hamster ovary (CHO) cells, but no invasion of Madin-Darby canine kidney (MDCK) cells 110. Both laminin and fibronectin are known targets for Y. pestis Ail binding 111 and vitronectin is actively recruited to the Y. pestis surface through the activities of Ail 112. Interestingly, Y. pseudotuberculosis Ail is unable to promote the attachment and invasion phenotypes when expressed in Escherichia coli 113. As with invasin, Ail-mediated tight attachment to host cells presumably ensures that Yop delivery is rapid and efficient 114. Aside from its adhesive properties, Ail also confers resistance to serum killing 115 in all three human pathogenic yersiniae. It is apparent that Ail plays a more prominent role in the virulence of Y. pestis, which is presumably owing to the fact that the other prominent virulence factors contributing many of the Ail functions in Y. pseudotuberculosis and Y. enterocolitica are dysfunctional.
Psa – the pH6 antigen
The chromosomally encoded pH6 antigen (Psa) was originally identified in Y. pestis as a surface antigen expressed at mammalian body temperatures at pH values similar to those found in phagolysosomes 116. It was subsequently found to cause the agglutination of erythrocytes 113, 117. Further investigation revealed a cell surface complex composed of aggregates of a 15 kDa protein (PsaA) that requires two regulators, PsaE and PsaF, for maximal induction 118, 119. PsaA possesses a flexible fimbrial structure that is highly expressed during macrophage infection 120. Biochemical examination of Psa reveals that it binds to β1-linked galactosyl residues in glycosphingolipids 121, mainly of the type found in apolipoprotein-B-containing lipoproteins in human plasma, such as low-density lipoprotein (LDL) and in lipid rafts in macrophage membranes 122. Furthermore, Psa acts as a bacterial Fc receptor, binding human immunoglobulin (IgG) but not reacting with rabbit, mouse, or sheep IgG 123. As with the other adhesins, the activities of Psa appear to mediate Yop secretion. Y. pseudotuberculosis and Y. enterocolitica both produce a surface protein analogous to Psa but it is referred to as MyfA. Both Psa and MyfA coat the bacterial surface with a fibrillar matrix 120, 124 and in Y. pseudotuberculosis MyfA promotes attachment to tissue culture cells and haemagglutination 113.
Y. pestis plasmid-specific virulence factors
Apart from the T3SS virulence plasmid, two other plasmids, pPCP and pMT (sometimes referred to as pFra) that are unique to Y. pestis, possess additional virulence factors. pPCP encodes the plasminogen activator Pla protease/adhesin ( Figure 3). Pla converts plasminogen to plasmin 125, 126, which then degrades extracellular matrices and confers on Y. pestis the ability to rapidly invade the host and migrate to lymphatic tissues 127, 128. The over-activation of plasmin results in laminin and fibrin clot degradation, exacerbating migration across host barriers 129, which is further compounded by the activities of Pla as an adhesin and an invasin 130, 131. pMT is responsible for the production of a murine toxin that is required during the colonisation of fleas 132.
Concluding remarks
Over the last three decades, a considerable amount of detailed knowledge has accumulated that has enabled us to understand how the yersiniae colonise tissues and combat host defences during infection. While the Yersinia T3SS is perhaps the best understood system of its kind, many questions remain unanswered. For example, fully elucidating the function of YopM will offer an important step change, as will understanding more clearly the global molecular mechanisms that underpin the regulatory relationships that must exist between the T3SS system and the adhesins. It is also important to try to understand the relationships that exist between the different adhesins, how they compensate for each other, and which environmental signals dictate their site-specific expression. Finally, although the structures of many of the adhesins have been elucidated, there is certainly a need to better understand how they interact with different host ligands. While significant progress has been made in defining this sophisticated and finely tuned arsenal of virulence determinants, much more work is required to fully appreciate the success of the yersiniae as pathogens.
Editorial Note on the Review Process
F1000 Faculty Reviews are commissioned from members of the prestigious F1000 Faculty and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).
The referees who approved this article are:
Andrew Roe, Institute of Infection, Immunity and Inflammation, and Institute of Molecular, Cell and Systems Biology, University of Glasgow, Glasgow, UK
James Bliska, Center for Infectious Diseases and Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY, USA
Funding Statement
The author(s) declared that no grants were involved in supporting this work.
[version 1; referees: 2 approved]
References
- 1. Achtman M, Zurth K, Morelli G, et al. : Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A. 1999;96(24):14043–8. 10.1073/pnas.96.24.14043 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Achtman M, Morelli G, Zhu P, et al. : Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci U S A. 2004;101(51):17837–42. 10.1073/pnas.0408026101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Prentice MB, Rahalison L: Plague. Lancet. 2007;369(9568):1196–207. 10.1016/S0140-6736(07)60566-2 [DOI] [PubMed] [Google Scholar]
- 4. Stenseth NC, Atshabar BB, Begon M, et al. : Plague: past, present, and future. PLoS Med. 2008;5(1):e3. 10.1371/journal.pmed.0050003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Guiyoule A, Gerbaud G, Buchrieser C, et al. : Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg Infect Dis. 2001;7(1):43–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Wren BW: The yersiniae--a model genus to study the rapid evolution of bacterial pathogens. Nat Rev Microbiol. 2003;1(1):55–64. 10.1038/nrmicro730 [DOI] [PubMed] [Google Scholar]
- 7. Trosky JE, Liverman AD, Orth K: Yersinia outer proteins: Yops. Cell Microbiol. 2008;10(3):557–65. 10.1111/j.1462-5822.2007.01109.x [DOI] [PubMed] [Google Scholar]
- 8. Diepold A, Armitage JP: Type III secretion systems: the bacterial flagellum and the injectisome. Philos Trans R Soc Lond, B Biol Sci. 2015;370(1679): pii: 20150020. 10.1098/rstb.2015.0020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Diepold A, Amstutz M, Abel S, et al. : Deciphering the assembly of the Yersinia type III secretion injectisome. EMBO J. 2010;29(11):1928–40. 10.1038/emboj.2010.84 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Edqvist PJ, Olsson J, Lavander M, et al. : YscP and YscU regulate substrate specificity of the Yersinia type III secretion system. J Bacteriol. 2003;185(7):2259–66. 10.1128/JB.185.7.2259-2266.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Sorg I, Wagner S, Amstutz M, et al. : YscU recognizes translocators as export substrates of the Yersinia injectisome. EMBO J. 2007;26(12):3015–24. 10.1038/sj.emboj.7601731 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Jackson MW, Plano GV: Interactions between type III secretion apparatus components from Yersinia pestis detected using the yeast two-hybrid system. FEMS Microbiol Lett. 2000;186(1):85–90. 10.1111/j.1574-6968.2000.tb09086.x [DOI] [PubMed] [Google Scholar]
- 13. Zarivach R, Vuckovic M, Deng W, et al. : Structural analysis of a prototypical ATPase from the type III secretion system. Nat Struct Mol Biol. 2007;14(2):131–7. 10.1038/nsmb1196 [DOI] [PubMed] [Google Scholar]
- 14. Woestyn S, Allaoui A, Wattiau P, et al. : YscN, the putative energizer of the Yersinia Yop secretion machinery. J Bacteriol. 1994;176(6):1561–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Hoiczyk E, Blobel G: Polymerization of a single protein of the pathogen Yersinia enterocolitica into needles punctures eukaryotic cells. Proc Natl Acad Sci U S A. 2001;98(8):4669–74. 10.1073/pnas.071065798 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Cornelis GR: The type III secretion injectisome. Nat Rev Microbiol. 2006;4(11):811–25. 10.1038/nrmicro1526 [DOI] [PubMed] [Google Scholar]
- 17. Stainier I, Bleves S, Josenhans C, et al. : YscP, a Yersinia protein required for Yop secretion that is surface exposed, and released in low Ca 2+. Mol Microbiol. 2000;37(5):1005–18. 10.1046/j.1365-2958.2000.02026.x [DOI] [PubMed] [Google Scholar]
- 18. Wagner S, Sorg I, Degiacomi M, et al. : The helical content of the YscP molecular ruler determines the length of the Yersinia injectisome. Mol Microbiol. 2009;71(3):692–701. 10.1111/j.1365-2958.2008.06556.x [DOI] [PubMed] [Google Scholar]
- 19. Payne PL, Straley SC: YscP of Yersinia pestis is a secreted component of the Yop secretion system. J Bacteriol. 1999;181(9):2852–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Kudryashev M, Diepold A, Amstutz M, et al. : Yersinia enterocolitica type III secretion injectisomes form regularly spaced clusters, which incorporate new machines upon activation. Mol Microbiol. 2015;95(5):875–84. 10.1111/mmi.12908 [DOI] [PubMed] [Google Scholar]
- 21. Broz P, Mueller CA, Müller SA, et al. : Function and molecular architecture of the Yersinia injectisome tip complex. Mol Microbiol. 2007;65(5):1311–20. 10.1111/j.1365-2958.2007.05871.x [DOI] [PubMed] [Google Scholar]
- 22. Mueller CA, Broz P, Müller SA, et al. : The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science. 2005;310(5748):674–6. 10.1126/science.1118476 [DOI] [PubMed] [Google Scholar]
- 23. Håkansson S, Bergman T, Vanooteghem JC, et al. : YopB and YopD constitute a novel class of Yersinia Yop proteins. Infect Immun. 1993;61(1):71–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Neyt C, Cornelis GR: Role of SycD, the chaperone of the Yersinia Yop translocators YopB and YopD. Mol Microbiol. 1999;31(1):143–56. 10.1046/j.1365-2958.1999.01154.x [DOI] [PubMed] [Google Scholar]
- 25. Bröms JE, Forslund AL, Forsberg A, et al. : Dissection of homologous translocon operons reveals a distinct role for YopD in type III secretion by Yersinia pseudotuberculosis. Microbiology. 2003;149(Pt 9):2615–26. 10.1099/mic.0.26322-0 [DOI] [PubMed] [Google Scholar]
- 26. Holmström A, Olsson J, Cherepanov P, et al. : LcrV is a channel size-determining component of the Yop effector translocon of Yersinia. Mol Microbiol. 2001;39(3):620–32. 10.1046/j.1365-2958.2001.02259.x [DOI] [PubMed] [Google Scholar]
- 27. DeBord KL, Lee VT, Schneewind O: Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica. J Bacteriol. 2001;183(15):4588–98. 10.1128/JB.183.15.4588-4598.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Lee VT, Schneewind O: Type III machines of pathogenic yersiniae secrete virulence factors into the extracellular milieu. Mol Microbiol. 1999;31(6):1619–29. 10.1046/j.1365-2958.1999.01270.x [DOI] [PubMed] [Google Scholar]
- 29. Cheng LW, Schneewind O: Yersinia enterocolitica TyeA, an intracellular regulator of the type III machinery, is required for specific targeting of YopE, YopH, YopM, and YopN into the cytosol of eukaryotic cells. J Bacteriol. 2000;182(11):3183–90. 10.1128/JB.182.11.3183-3190.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Cornelis GR, Wolf-Watz H: The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol. 1997;23(5):861–7. 10.1046/j.1365-2958.1997.2731623.x [DOI] [PubMed] [Google Scholar]
- 31. Woestyn S, Sory MP, Boland A, et al. : The cytosolic SycE and SycH chaperones of Yersinia protect the region of YopE and YopH involved in translocation across eukaryotic cell membranes. Mol Microbiol. 1996;20(6):1261–71. 10.1111/j.1365-2958.1996.tb02645.x [DOI] [PubMed] [Google Scholar]
- 32. Cheng LW, Schneewind O: Yersinia enterocolitica type III secretion. On the role of SycE in targeting YopE into HeLa cells. J Biol Chem. 1999;274(31):22102–8. 10.1074/jbc.274.31.22102 [DOI] [PubMed] [Google Scholar]
- 33. Evdokimov AG, Tropea JE, Routzahn KM, et al. : Crystal structure of the Yersinia pestis GTPase activator YopE. Protein Sci. 2002;11(2):401–8. 10.1110/ps.34102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Black DS, Bliska JB: The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol Microbiol. 2000;37(3):515–27. 10.1046/j.1365-2958.2000.02021.x [DOI] [PubMed] [Google Scholar]
- 35. Aili M, Isaksson EL, Hallberg B, et al. : Functional analysis of the YopE GTPase-activating protein (GAP) activity of Yersinia pseudotuberculosis. Cell Microbiol. 2006;8(6):1020–33. 10.1111/j.1462-5822.2005.00684.x [DOI] [PubMed] [Google Scholar]
- 36. Andor A, Trülzsch K, Essler M, et al. : YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells. Cell Microbiol. 2001;3(5):301–10. 10.1046/j.1462-5822.2001.00114.x [DOI] [PubMed] [Google Scholar]
- 37. Shao F, Merritt PM, Bao Z, et al. : A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell. 2002;109(5):575–88. 10.1016/S0092-8674(02)00766-3 [DOI] [PubMed] [Google Scholar]
- 38. Aepfelbacher M, Trasak C, Wiedemann A, et al. : Rho-GTP binding proteins in Yersinia target cell interaction. Adv Exp Med Biol. 2003;529:65–72. 10.1007/0-306-48416-1_12 [DOI] [PubMed] [Google Scholar]
- 39. Schmidt G: Yersinia enterocolitica outer protein T (YopT). Eur J Cell Biol. 2011;90(11):955–8. 10.1016/j.ejcb.2010.12.005 [DOI] [PubMed] [Google Scholar]
- 40. Barz C, Abahji TN, Trülzsch K, et al. : The Yersinia Ser/Thr protein kinase YpkA/YopO directly interacts with the small GTPases RhoA and Rac-1. FEBS Lett. 2000;482(1–2):139–43. 10.1016/S0014-5793(00)02045-7 [DOI] [PubMed] [Google Scholar]
- 41. Groves E, Rittinger K, Amstutz M, et al. : Sequestering of Rac by the Yersinia effector YopO blocks Fcgamma receptor-mediated phagocytosis. J Biol Chem. 2010;285(6):4087–98. 10.1074/jbc.M109.071035 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Navarro L, Koller A, Nordfelth R, et al. : Identification of a molecular target for the Yersinia protein kinase A. Mol Cell. 2007;26(4):465–77. 10.1016/j.molcel.2007.04.025 [DOI] [PubMed] [Google Scholar]
- 43. Juris SJ, Rudolph AE, Huddler D, et al. : A distinctive role for the Yersinia protein kinase: actin binding, kinase activation, and cytoskeleton disruption. Proc Natl Acad Sci U S A. 2000;97(17):9431–6. 10.1073/pnas.170281997 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Lee WL, Grimes JM, Robinson RC: Yersinia effector YopO uses actin as bait to phosphorylate proteins that regulate actin polymerization. Nat Struct Mol Biol. 2015;22(3):248–55. 10.1038/nsmb.2964 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Cantwell AM, Bubeck SS, Dube PH: YopH inhibits early pro-inflammatory cytokine responses during plague pneumonia. BMC Immunol. 2010;11:29. 10.1186/1471-2172-11-29 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Logsdon LK, Mecsas J: Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect Immun. 2003;71(8):4595–607. 10.1128/IAI.71.8.4595-4607.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Trülzsch K, Sporleder T, Igwe EI, et al. : Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect Immun. 2004;72(9):5227–34. 10.1128/IAI.72.9.5227-5234.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Deuretzbacher A, Czymmeck N, Reimer R, et al. : Beta1 integrin-dependent engulfment of Yersinia enterocolitica by macrophages is coupled to the activation of autophagy and suppressed by type III protein secretion. J Immunol. 2009;183(9):5847–60. 10.4049/jimmunol.0804242 [DOI] [PubMed] [Google Scholar]
- 49. Rosqvist R, Skurnik M, Wolf-Watz H: Increased virulence of Yersinia pseudotuberculosis by two independent mutations. Nature. 1988;334(6182):522–4. 10.1038/334522a0 [DOI] [PubMed] [Google Scholar]
- 50. Bölin I, Wolf-Watz H: The plasmid-encoded Yop2b protein of Yersinia pseudotuberculosis is a virulence determinant regulated by calcium and temperature at the level of transcription. Mol Microbiol. 1988;2(2):237–45. 10.1111/j.1365-2958.1988.tb00025.x [DOI] [PubMed] [Google Scholar]
- 51. Bliska JB, Guan KL, Dixon JE, et al. : Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci U S A. 1991;88(4):1187–91. 10.1073/pnas.88.4.1187 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Navarro L, Alto NM, Dixon JE: Functions of the Yersinia effector proteins in inhibiting host immune responses. Curr Opin Microbiol. 2005;8(1):21–7. 10.1016/j.mib.2004.12.014 [DOI] [PubMed] [Google Scholar]
- 53. Grosdent N, Maridonneau-Parini I, Sory MP, et al. : Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun. 2002;70(8):4165–76. 10.1128/IAI.70.8.4165-4176.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Shao F: Biochemical functions of Yersinia type III effectors. Curr Opin Microbiol. 2008;11(1):21–9. 10.1016/j.mib.2008.01.005 [DOI] [PubMed] [Google Scholar]
- 55. Matsumoto H, Young GM: Translocated effectors of Yersinia. Curr Opin Microbiol. 2009;12(1):94–100. 10.1016/j.mib.2008.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Cornelis GR: The Yersinia Ysc-Yop 'type III' weaponry. Nat Rev Mol Cell Biol. 2002;3(10):742–52. 10.1038/nrm932 [DOI] [PubMed] [Google Scholar]
- 57. Cornelis GR: Yersinia type III secretion: send in the effectors. J Cell Biol. 2002;158(3):401–8. 10.1083/jcb.200205077 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Mukherjee S, Keitany G, Li Y, et al. : Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science. 2006;312(5777):1211–4. 10.1126/science.1126867 [DOI] [PubMed] [Google Scholar]
- 59. Orth K, Xu Z, Mudgett MB, et al. : Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science. 2000;290(5496):1594–7. 10.1126/science.290.5496.1594 [DOI] [PubMed] [Google Scholar]
- 60. Mittal R, Peak-Chew SY, McMahon HT: Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci U S A. 2006;103(49):18574–9. 10.1073/pnas.0608995103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Ruckdeschel K, Harb S, Roggenkamp A, et al. : Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J Exp Med. 1998;187(7):1069–79. 10.1084/jem.187.7.1069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Boland A, Cornelis GR: Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect Immun. 1998;66(5):1878–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Schoberle TJ, Chung LK, McPhee JB, et al. : Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence. Infect Immun. 2016;84(4):1062–72. 10.1128/IAI.00843-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Boland A, Sory MP, Iriarte M, et al. : Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y.enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus. EMBO J. 1996;15(19):5191–201. [PMC free article] [PubMed] [Google Scholar]
- 65. Bertrand J, Ruther C, Scharnert J, et al. : The bacterial effector protein YopM is a selfdelivering immune therapeutic agent that reduces inflammation in rheumatoid arthritis. Ann Rheum Dis. 2010;69:A47 10.1136/ard.2010.129635j [DOI] [Google Scholar]
- 66. Höfling S, Grabowski B, Norkowski S, et al. : Current activities of the Yersinia effector protein YopM. Int J Med Microbiol. 2015;305(3):424–32. 10.1016/j.ijmm.2015.03.009 [DOI] [PubMed] [Google Scholar]
- 67. Hentschke M, Berneking L, Belmar Campos C, et al. : Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation. PLoS One. 2010;5(10): pii: e13165. 10.1371/journal.pone.0013165 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Benabdillah R, Mota LJ, Lützelschwab S, et al. : Identification of a nuclear targeting signal in YopM from Yersinia spp. Microb Pathog. 2004;36(5):247–61. 10.1016/j.micpath.2003.12.006 [DOI] [PubMed] [Google Scholar]
- 69. Skrzypek E, Myers-Morales T, Whiteheart SW, et al. : Application of a Saccharomyces cerevisiae model to study requirements for trafficking of Yersinia pestis YopM in eucaryotic cells. Infect Immun. 2003;71(2):937–47. 10.1128/IAI.71.2.937-947.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Skrzypek E, Cowan C, Straley SC: Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus. Mol Microbiol. 1998;30(5):1051–65. 10.1046/j.1365-2958.1998.01135.x [DOI] [PubMed] [Google Scholar]
- 71. Ye Z, Kerschen EJ, Cohen DA, et al. : Gr1 + cells control growth of YopM-negative yersinia pestis during systemic plague. Infect Immun. 2009;77(9):3791–806. 10.1128/IAI.00284-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Kerschen EJ, Cohen DA, Kaplan AM, et al. : The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun. 2004;72(8):4589–602. 10.1128/IAI.72.8.4589-4602.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. LaRock CN, Cookson BT: The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. Cell Host Microbe. 2012;12(6):799–805. 10.1016/j.chom.2012.10.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Chung LK, Philip NH, Schmidt VA, et al. : IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM. MBio. 2014;5(4):e01402–14. 10.1128/mBio.01402-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Isberg RR, Voorhis DL, Falkow S: Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell. 1987;50(5):769–78. 10.1016/0092-8674(87)90335-7 [DOI] [PubMed] [Google Scholar]
- 76. Parkhill J, Wren BW, Thomson NR, et al. : Genome sequence of Yersinia pestis, the causative agent of plague. Nature. 2001;413(6855):523–7. 10.1038/35097083 [DOI] [PubMed] [Google Scholar]
- 77. Clark MA, Hirst BH, Jepson MA: M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect Immun. 1998;66(3):1237–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Hamburger ZA, Brown MS, Isberg RR, et al. : Crystal structure of invasin: a bacterial integrin-binding protein. Science. 1999;286(5438):291–5. 10.1126/science.286.5438.291 [DOI] [PubMed] [Google Scholar]
- 79. Isberg RR, Swain A, Falkow S: Analysis of expression and thermoregulation of the Yersinia pseudotuberculosis inv gene with hybrid proteins. Infect Immun. 1988;56(8):2133–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Pepe JC, Badger JL, Miller VL: Growth phase and low pH affect the thermal regulation of the Yersinia enterocolitica inv gene. Mol Microbiol. 1994;11(1):123–35. 10.1111/j.1365-2958.1994.tb00295.x [DOI] [PubMed] [Google Scholar]
- 81. Grassl GA, Bohn E, Müller Y, et al. : Interaction of Yersinia enterocolitica with epithelial cells: invasin beyond invasion. Int J Med Microbiol. 2003;293(1):41–54. 10.1078/1438-4221-00243 [DOI] [PubMed] [Google Scholar]
- 82. Uliczka F, Pisano F, Kochut A, et al. : Monitoring of gene expression in bacteria during infections using an adaptable set of bioluminescent, fluorescent and colorigenic fusion vectors. PLoS One. 2011;6(6):e20425. 10.1371/journal.pone.0020425 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Nagel G, Lahrz A, Dersch P: Environmental control of invasin expression in Yersinia pseudotuberculosis is mediated by regulation of RovA, a transcriptional activator of the SlyA/Hor family. Mol Microbiol. 2001;41(6):1249–6. 10.1046/j.1365-2958.2001.02522.x [DOI] [PubMed] [Google Scholar]
- 84. Revell PA, Miller VL: A chromosomally encoded regulator is required for expression of the Yersinia enterocolitica inv gene and for virulence. Mol Microbiol. 2000;35(3):677–85. 10.1046/j.1365-2958.2000.01740.x [DOI] [PubMed] [Google Scholar]
- 85. Ellison DW, Young B, Nelson K, et al. : YmoA negatively regulates expression of invasin from Yersinia enterocolitica. J Bacteriol. 2003;185(24):7153–9. 10.1128/JB.185.24.7153-7159.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Heroven AK, Nagel G, Tran HJ, et al. : RovA is autoregulated and antagonizes H-NS-mediated silencing of invasin and rovA expression in Yersinia pseudotuberculosis. Mol Microbiol. 2004;53(3):871–88. 10.1111/j.1365-2958.2004.04162.x [DOI] [PubMed] [Google Scholar]
- 87. Ellison DW, Miller VL: H-NS represses inv transcription in Yersinia enterocolitica through competition with RovA and interaction with YmoA. J Bacteriol. 2006;188(14):5101–12. 10.1128/JB.00862-05 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Heroven AK, Dersch P: RovM, a novel LysR-type regulator of the virulence activator gene rovA, controls cell invasion, virulence and motility of Yersinia pseudotuberculosis. Mol Microbiol. 2006;62(5):1469–83. 10.1111/j.1365-2958.2006.05458.x [DOI] [PubMed] [Google Scholar]
- 89. Mühlenkamp M, Oberhettinger P, Leo JC, et al. : Yersinia adhesin A (YadA)--beauty & beast. Int J Med Microbiol. 2015;305(2):252–8. 10.1016/j.ijmm.2014.12.008 [DOI] [PubMed] [Google Scholar]
- 90. Skurnik M, Toivanen P: LcrF is the temperature-regulated activator of the yadA gene of Yersinia enterocolitica and Yersinia pseudotuberculosis. J Bacteriol. 1992;174(6):2047–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Zaleska M, Lounatmaa K, Nurminen M, et al. : A novel virulence-associated cell surface structure composed of 47-kd protein subunits in Yersinia enterocolitica. EMBO J. 1985;4(4):1013–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Hoiczyk E, Roggenkamp A, Reichenbecher M, et al. : Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. EMBO J. 2000;19(22):5989–99. 10.1093/emboj/19.22.5989 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Skurnik M, Wolf-Watz H: Analysis of the yopA gene encoding the Yop1 virulence determinants of Yersinia spp. Mol Microbiol. 1989;3(4):517–29. 10.1111/j.1365-2958.1989.tb00198.x [DOI] [PubMed] [Google Scholar]
- 94. Forman S, Wulff CR, Myers-Morales T, et al. : yadBC of Yersinia pestis, a new virulence determinant for bubonic plague. Infect Immun. 2008;76(2): 578–87. 10.1128/IAI.00219-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Mikula KM, Kolodziejczyk R, Goldman A: Yersinia infection tools-characterization of structure and function of adhesins. Front Cell Infect Microbiol. 2013;2:169. 10.3389/fcimb.2012.00169 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Visser LG, Annema A, van Furth R: Role of Yops in inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes. Infect Immun. 1995;63(7):2570–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. El Tahir Y, Skurnik M: YadA, the multifaceted Yersinia adhesin. Int J Med Microbiol. 2001;291(3):209–18. 10.1078/1438-4221-00119 [DOI] [PubMed] [Google Scholar]
- 98. Tertti R, Skurnik M, Vartio T, et al. : Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun. 1992;60(7):3021–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Flügel A, Schulze-Koops H, Heesemann J, et al. : Interaction of enteropathogenic Yersinia enterocolitica with complex basement membranes and the extracellular matrix proteins collagen type IV, laminin-1 and -2, and nidogen/entactin. J Biol Chem. 1994;269(47):29732–8. [PubMed] [Google Scholar]
- 100. Keller B, Mühlenkamp M, Deuschle E, et al. : Yersinia enterocolitica exploits different pathways to accomplish adhesion and toxin injection into host cells. Cell Microbiol. 2015;17(8):1179–204. 10.1111/cmi.12429 [DOI] [PubMed] [Google Scholar]
- 101. Deuschle E, Keller B, Siegfried A, et al. : Role of β1 integrins and bacterial adhesins for Yop injection into leukocytes in Yersinia enterocolitica systemic mouse infection. Int J Med Microbiol. 2016;306(2):77–88. 10.1016/j.ijmm.2015.12.001 [DOI] [PubMed] [Google Scholar]
- 102. Eitel J, Dersch P: The YadA protein of Yersinia pseudotuberculosis mediates high-efficiency uptake into human cells under environmental conditions in which invasin is repressed. Infect Immun. 2002;70(9):4880–91. 10.1128/IAI.70.9.4880-4891.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103. Heise T, Dersch P: Identification of a domain in Yersinia virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake. Proc Natl Acad Sci U S A. 2006;103(9):3375–80. 10.1073/pnas.0507749103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. Mantle M, Husar SD: Binding of Yersinia enterocolitica to purified, native small intestinal mucins from rabbits and humans involves interactions with the mucin carbohydrate moiety. Infect Immun. 1994;62(4):1219–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Biedzka-Sarek M, Jarva H, Hyytiäinen H, et al. : Characterization of complement factor H binding to Yersinia enterocolitica serotype O:3. Infect Immun. 2008;76(9):4100–9. 10.1128/IAI.00313-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106. Biedzka-Sarek M, Salmenlinna S, Gruber M, et al. : Functional mapping of YadA- and Ail-mediated binding of human factor H to Yersinia enterocolitica serotype O:3. Infect Immun. 2008;76(11):5016–27. 10.1128/IAI.00314-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. Kirjavainen V, Jarva H, Biedzka-Sarek M, et al. : Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein. PLoS Pathog. 2008;4(8):e1000140. 10.1371/journal.ppat.1000140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Miller VL, Falkow S: Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells. Infect Immun. 1988;56(5):1242–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109. Miller VL, Bliska JB, Falkow S: Nucleotide sequence of the Yersinia enterocolitica ail gene and characterization of the Ail protein product. J Bacteriol. 1990;172(2):1062–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110. Miller VL, Mekalanos JJ: A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol. 1988;170(6):2575–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111. Yamashita S, Lukacik P, Barnard TJ, et al. : Structural insights into Ail-mediated adhesion in Yersinia pestis. Structure. 2011;19(11):1672–82. 10.1016/j.str.2011.08.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112. Bartra SS, Ding Y, Fujimoto LM, et al. : Yersinia pestis uses the Ail outer membrane protein to recruit vitronectin. Microbiology. 2015;161(11):2174–83. 10.1099/mic.0.000179 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Yang Y, Merriam JJ, Mueller JP, et al. : The psa locus is responsible for thermoinducible binding of Yersinia pseudotuberculosis to cultured cells. Infect Immun. 1996;64(7):2483–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114. Felek S, Muszyński A, Carlson RW, et al. : Phosphoglucomutase of Yersinia pestis is required for autoaggregation and polymyxin B resistance. Infect Immun. 2010;78(3):1163–75. 10.1128/IAI.00997-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. Pierson DE, Falkow S: The ail gene of Yersinia enterocolitica has a role in the ability of the organism to survive serum killing. Infect Immun. 1993;61(5):1846–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116. Ben-Efraim S, Aronson M, Bichowsky-Slomnicki L: New antigenic component of Pasteurella pestis formed under specified conditions of pH and temperature. J Bacteriol. 1961;81(5):704–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117. Bichowsky-Slomnicki L, Ben-Efraim S: Biological activities in extracts of Pasteurella pestis and their relation to the "pH 6 antigen". J Bacteriol. 1963;86(1):101–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118. Lindler LE, Klempner MS, Straley SC: Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague. Infect Immun. 1990;58(8):2569–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119. Yang Y, Isberg RR: Transcriptional regulation of the Yersinia pseudotuberculosis pH6 antigen adhesin by two envelope-associated components. Mol Microbiol. 1997;24(3):499–510. 10.1046/j.1365-2958.1997.3511719.x [DOI] [PubMed] [Google Scholar]
- 120. Lindler LE, Tall BD: Yersinia pestis pH 6 antigen forms fimbriae and is induced by intracellular association with macrophages. Mol Microbiol. 1993;8(2):311–24. 10.1111/j.1365-2958.1993.tb01575.x [DOI] [PubMed] [Google Scholar]
- 121. Payne D, Tatham D, Williamson ED, et al. : The pH 6 antigen of Yersinia pestis binds to beta1-linked galactosyl residues in glycosphingolipids. Infect Immun. 1998;66(9):4545–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122. Makoveichuk E, Cherepanov P, Lundberg S, et al. : pH6 antigen of Yersinia pestis interacts with plasma lipoproteins and cell membranes. J Lipid Res. 2003;44(2):320–30. 10.1194/jlr.M200182-JLR200 [DOI] [PubMed] [Google Scholar]
- 123. Zav'yalov VP, Abramov VM, Cherepanov PG, et al. : pH6 antigen (PsaA protein) of Yersinia pestis, a novel bacterial Fc-receptor. FEMS Immunol Med Microbiol. 1996;14(1):53–7. 10.1111/j.1574-695X.1996.tb00267.x [DOI] [PubMed] [Google Scholar]
- 124. Iriarte M, Vanooteghem JC, Delor I, et al. : The Myf fibrillae of Yersinia enterocolitica. Mol Microbiol. 1993;9(3):507–20. 10.1111/j.1365-2958.1993.tb01712.x [DOI] [PubMed] [Google Scholar]
- 125. Beesley ED, Brubaker RR, Janssen WA, et al. : Pesticins. 3. Expression of coagulase and mechanism of fibrinolysis. J Bacteriol. 1967;94(1):19–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126. Degen JL, Bugge TH, Goguen JD: Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost. 2007;5(Suppl 1):24–31. 10.1111/j.1538-7836.2007.02519.x [DOI] [PubMed] [Google Scholar]
- 127. Plow EF, Ploplis VA, Carmeliet P, et al. : Plasminogen and cell migration in vivo. Fibrinolysis Proteol. 1999;13(2):49–53. 10.1016/S0268-9499(99)90079-6 [DOI] [Google Scholar]
- 128. Sebbane F, Jarrett CO, Gardner D, et al. : Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci U S A. 2006;103(14):5526–30. 10.1073/pnas.0509544103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129. Haiko J, Kukkonen M, Ravantti JJ, et al. : The single substitution I259T, conserved in the plasminogen activator Pla of pandemic Yersinia pestis branches, enhances fibrinolytic activity. J Bacteriol. 2009;191(15):4758–66. 10.1128/JB.00489-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130. Kienle Z, Emödy L, Svanborg C, et al. : Adhesive properties conferred by the plasminogen activator of Yersinia pestis. J Gen Microbiol. 1992;138(Pt 8):1679–87. 10.1099/00221287-138-8-1679 [DOI] [PubMed] [Google Scholar]
- 131. Lähteenmäki K, Kukkonen M, Korhonen TK: The Pla surface protease/adhesin of Yersinia pestis mediates bacterial invasion into human endothelial cells. FEBS Lett. 2001;504(1–2):69–72. 10.1016/S0014-5793(01)02775-2 [DOI] [PubMed] [Google Scholar]
- 132. Hinnebusch BJ, Rudolph AE, Cherepanov P, et al. : Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science. 2002;296(5568):733–5. 10.1126/science.1069972 [DOI] [PubMed] [Google Scholar]
- 133. Wiechmann A: Quorum sensing and the regulation of multicellular behaviour in Yersinia pseudotuberculosis.(PhD Thesis. The University of Nottingham). [Google Scholar]
- 134. Schraidt O, Lefebre MD, Brunner MJ, et al. : Topology and organization of the Salmonella typhimurium type III secretion needle complex components. PLoS Pathog. 2010;6(4):e1000824. 10.1371/journal.ppat.1000824 [DOI] [PMC free article] [PubMed] [Google Scholar]